Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析

◆英語タイトル:Amryt Pharma Plc (AMYT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH417512FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amryt Pharma Plc (AMYT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amryt Pharma Plc (Amryt Pharma) is a biopharmaceutical company which develops and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include lomitapide for the treatment of adult HoFH and Metreleptin for the treatment of leptin deficiency. The company is also developing a portfolio of pipeline candidates, AP101 and AP103 targeting multiple orphan diseases such as epidermolysis bullosa. The company offers its products in the US, European Middle East and Africa (EMEA). Amryt Pharma is headquartered in London, the UK.

Amryt Pharma Plc Key Recent Developments

Nov 05,2020: Amryt reports record Q3 2020 results – raising FY 2020 revenue guidance
Aug 07,2020: Amryt to present at Virtual Canaccord Genuity 40th Annual Growth Conference
Aug 06,2020: Amryt announces Q2 2020 results
Aug 06,2020: Amryt announces Q2 2020 results and issues positive revenue guidance for FY 2020
May 11,2020: Amryt Pharma : Q1 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amryt Pharma Plc – Key Facts
Amryt Pharma Plc – Key Employees
Amryt Pharma Plc – Key Employee Biographies
Amryt Pharma Plc – Major Products and Services
Amryt Pharma Plc – History
Amryt Pharma Plc – Company Statement
Amryt Pharma Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amryt Pharma Plc – Business Description
Product Category: Lojuxta
Performance
Product Category: Lomitapide
Overview
Product Category: Metreleptin
Overview
Performance
Product Category: Others
Overview
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Amryt Pharma Plc – Corporate Strategy
Amryt Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Amryt Pharma Plc – Strengths
Amryt Pharma Plc – Weaknesses
Amryt Pharma Plc – Opportunities
Amryt Pharma Plc – Threats
Amryt Pharma Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amryt Pharma Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2020: Amryt reports record Q3 2020 results – raising FY 2020 revenue guidance
Aug 07, 2020: Amryt to present at Virtual Canaccord Genuity 40th Annual Growth Conference
Aug 06, 2020: Amryt announces Q2 2020 results
Aug 06, 2020: Amryt announces Q2 2020 results and issues positive revenue guidance for FY 2020
May 11, 2020: Amryt Pharma : Q1 2020 results
May 11, 2020: Amryt Pharma : FY 2019 results
Mar 23, 2020: AMRYT PHARMA: Strong cash balances coupled with revenue progression
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amryt Pharma Plc, Key Facts
Amryt Pharma Plc, Key Employees
Amryt Pharma Plc, Key Employee Biographies
Amryt Pharma Plc, Major Products and Services
Amryt Pharma Plc, History
Amryt Pharma Plc, Other Locations
Amryt Pharma Plc, Subsidiaries
Amryt Pharma Plc, Key Competitors
Amryt Pharma Plc, Ratios based on current share price
Amryt Pharma Plc, Annual Ratios
Amryt Pharma Plc, Annual Ratios (Cont...1)
Amryt Pharma Plc, Interim Ratios
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amryt Pharma Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Regis Healthcare Ltd:企業の戦略・SWOT・財務情報
    Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AT&T Inc:戦略・SWOT・企業財務分析
    AT&T Inc - Strategy, SWOT and Corporate Finance Report Summary AT&T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Gelsenwasser AG (WWG):企業の財務・戦略的SWOT分析
    Summary Gelsenwasser AG (Gelsenwasser) is a utility company that supplies natural gas and fresh water. The company distributes electricity, water, gas, and heat for residents in Germany. Its services include online service, repair services, energy performance certifications, debugging and installati …
  • Centre de Regulacio Genomica:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre de Regulacio Genomica (CRG) is a biomedical institute that offers healthcare research services. The institute offers research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offe …
  • Sinocare Meditech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sinocare Meditech Inc (Sinocare Meditech) formerly known as Freedom Meditech Inc, is a medical device company that provides ophthalmic medical devices. The company develops and commercializes ophthalmic medical devices for both chronic disease detection and the management of diabetes. It pro …
  • Galaxy Entertainment Group Ltd:企業の戦略・SWOT・財務情報
    Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Dai-ichi Life Holdings, Inc.:企業の戦略・SWOT・財務情報
    Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Epic Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Sciences Inc (Epic Sciences) focuses to develop novel diagnostics for personalized treatment of cancer. The company develops AR-V7 test to identify and molecularly characterize circulating tumor cells in a blood sample. It also offers biopharma solutions such as resistance to AR signali …
  • Leica Microsystems GmbH-医療機器分野:企業M&A・提携分析
    Summary Leica Microsystems GmbH (Leica), a subsidiary of Danaher Corp is a medical device company that manufactures microstructures. The company manufactures, and markets microscopes and scientific instruments. Its products include light microscopes, confocal microscopes, stereo microscopes and macr …
  • Somnomed Ltd (SOM)-医療機器分野:企業M&A・提携分析
    Summary Somnomed Ltd (SomnoMed) is medical device company that develops produces, commercializes and sells device for the oral treatment of sleep related disorders. The company’s products include somnodent, an oral appliance for obstructive sleep apnea; and somnobrux, a mouthguard that protects pati …
  • Smrt Corporation Ltd.
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Rush Enterprises, Inc. (RUSHA):企業の財務・戦略的SWOT分析
    Rush Enterprises, Inc. (RUSHA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BRF SA:企業の戦略・SWOT・財務情報
    BRF SA - Strategy, SWOT and Corporate Finance Report Summary BRF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Integra LifeSciences Holdings Corporation:企業のM&A・事業提携・投資動向
    Integra LifeSciences Holdings Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Integra LifeSciences Holdings Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • The Hershey Co:企業の戦略・SWOT・財務情報
    The Hershey Co - Strategy, SWOT and Corporate Finance Report Summary The Hershey Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Protea Biosciences Group Inc (PRGB):企業の財務・戦略的SWOT分析
    Summary Protea Biosciences Group Inc (Protea) operates as a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnosti …
  • Monster Worldwide Inc:企業の戦略的SWOT分析
    Monster Worldwide Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Petoro AS-石油・ガス分野:企業M&A・提携分析
    Summary Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state's direct …
  • Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆